Xingang Cui

1.6k total citations
36 papers, 638 citations indexed

About

Xingang Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xingang Cui has authored 36 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Xingang Cui's work include Epigenetics and DNA Methylation (9 papers), Ferroptosis and cancer prognosis (7 papers) and Renal cell carcinoma treatment (5 papers). Xingang Cui is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Ferroptosis and cancer prognosis (7 papers) and Renal cell carcinoma treatment (5 papers). Xingang Cui collaborates with scholars based in China, United States and Qatar. Xingang Cui's co-authors include Xiuwu Pan, Chuanmin Chu, Danfeng Xu, Yi Gao, Fajun Qu, Chao Wang, Sishun Gan, Qiwei Yang, Xiaopeng Duan and Ye Wang and has published in prestigious journals such as Biomaterials, Cell Death and Differentiation and Frontiers in Immunology.

In The Last Decade

Xingang Cui

35 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingang Cui China 13 333 191 152 142 88 36 638
Qin‐Sheng Mao China 17 499 1.5× 364 1.9× 109 0.7× 119 0.8× 78 0.9× 43 861
Teng Hou China 17 525 1.6× 319 1.7× 78 0.5× 130 0.9× 74 0.8× 41 861
Bi‐Wen Yeh Taiwan 18 311 0.9× 129 0.7× 90 0.6× 117 0.8× 57 0.6× 33 681
Yunfei Wen United States 12 389 1.2× 169 0.9× 65 0.4× 121 0.9× 70 0.8× 23 675
Xiufeng Hu China 15 522 1.6× 333 1.7× 145 1.0× 214 1.5× 139 1.6× 23 807
Kun Ke China 16 251 0.8× 140 0.7× 176 1.2× 161 1.1× 76 0.9× 39 586
Ziwei Zeng China 14 434 1.3× 271 1.4× 85 0.6× 235 1.7× 125 1.4× 50 811
Zhixian He China 14 333 1.0× 160 0.8× 61 0.4× 87 0.6× 53 0.6× 46 528

Countries citing papers authored by Xingang Cui

Since Specialization
Citations

This map shows the geographic impact of Xingang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingang Cui more than expected).

Fields of papers citing papers by Xingang Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingang Cui. The network helps show where Xingang Cui may publish in the future.

Co-authorship network of co-authors of Xingang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xingang Cui. A scholar is included among the top collaborators of Xingang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingang Cui. Xingang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yifan, Dawei Zhu, Xiangmin Zhang, et al.. (2024). Unveiling the unique role of TSPAN7 across tumors: a pan-cancer study incorporating retrospective clinical research and bioinformatic analysis. Biology Direct. 19(1). 72–72. 6 indexed citations
3.
Chen, Wenjin, Hao Cao, Jianwei Cao, et al.. (2022). Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study. Cell Death and Disease. 13(1). 50–50. 14 indexed citations
4.
Liu, Zhaopei, Kaifeng Jin, Han Zeng, et al.. (2022). B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer. European Journal of Cancer. 171. 133–142. 11 indexed citations
6.
Zhu, Dawei, Lei Zhang, Lifeng Zhang, et al.. (2021). RNF43 is a Novel Tumor Suppressor and Prognostic Indicator in Clear Cell Renal Cell Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 5 indexed citations
7.
Wang, Chao, Yuning Wang, Sishun Gan, et al.. (2020). Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma. Cell Death and Disease. 11(2). 117–117. 29 indexed citations
8.
Wang, Chao, Yuning Wang, Jianqing Ye, et al.. (2020). Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma. Cell Death and Differentiation. 28(3). 932–951. 31 indexed citations
9.
Song, Mei, Chao Wang, Huan Wang, et al.. (2020). Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response. OncoImmunology. 9(1). 1746148–1746148. 20 indexed citations
10.
Wang, Huan, Chao Wang, Guang Peng, et al.. (2019). Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis. Molecular Cancer Research. 18(2). 240–252. 6 indexed citations
11.
Liu, Xi, Lu Chen, Hong Yi, et al.. (2019). IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway. Cell Death and Disease. 10(7). 517–517. 49 indexed citations
12.
Cui, Hongjing, Xingang Cui, Xin He, et al.. (2018). PMT1 deficiency extends the shortened replicative lifespan of TED1-deficient yeast in a Hac1p-dependent manner. FEMS Microbiology Letters. 365(21). 2 indexed citations
13.
Cheng, Kejun, Lu Chen, Fajun Qu, et al.. (2018). α-Viniferin activates autophagic apoptosis and cell death by reducing glucocorticoid receptor expression in castration-resistant prostate cancer cells. Medical Oncology. 35(7). 105–105. 12 indexed citations
15.
Pan, Xiuwu, Lu Chen, Hong Yi, et al.. (2016). EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling. International Journal of Oncology. 48(6). 2580–2590. 39 indexed citations
16.
Cui, Xinyu, Hongmei Gu, Yue Guan, et al.. (2015). Fabrication of AgInS2 nanoparticles sensitized TiO2 nanotube arrays and their photoelectrochemical properties. Solar Energy Materials and Solar Cells. 137. 101–106. 30 indexed citations
17.
Chen, Jie, et al.. (2014). NOV is upregulated and promotes migration and invasion in bladder cancer. Tumor Biology. 35(7). 6749–6755. 5 indexed citations
18.
Xu, Danfeng, et al.. (2012). Low-frequency electrotherapy for female patients with detrusor underactivity due to neuromuscular deficiency. International Urogynecology Journal. 23(8). 1007–1015. 5 indexed citations
19.
Chang, Wenjun, Danfeng Xu, Xingang Cui, et al.. (2010). Relationship of GSTP1,RASSF1A polymorphisms and environmental agent with susceptibility to prostate cancer:a case-control study. Academic Journal of Second Military Medical University. 30(1). 12–17. 2 indexed citations
20.
Cui, Xingang, et al.. (2010). Association between neuropeptide oxytocin and male infertility. Journal of Assisted Reproduction and Genetics. 27(9-10). 525–531. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026